BSE Live
Jan 12, 16:01Prev. Close
173.95
Open Price
170.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 12, 15:58Prev. Close
173.97
Open Price
172.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Marksans Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 2.86 | 1.87 | 0.80 | 0.22 | 1.92 | |
| Diluted EPS (Rs.) | 2.86 | 1.87 | 0.80 | 0.22 | 1.92 | |
| Cash EPS (Rs.) | 3.60 | 2.52 | 1.53 | 1.01 | 2.71 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 15.86 | 13.50 | 11.74 | 10.74 | 11.00 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 15.86 | 13.50 | 11.74 | 10.74 | 11.00 | |
| Revenue from Operations/Share (Rs.) | 27.71 | 24.43 | 22.30 | 18.74 | 21.82 | |
| PBDIT/Share (Rs.) | 4.70 | 3.34 | 2.12 | 1.26 | 3.55 | |
| PBIT/Share (Rs.) | 4.05 | 2.78 | 1.47 | 0.53 | 2.86 | |
| PBT/Share (Rs.) | 3.84 | 2.55 | 1.22 | 0.36 | 2.61 | |
| Net Profit/Share (Rs.) | 2.95 | 1.97 | 0.87 | 0.28 | 2.02 | |
| NP After MI And SOA / Share (Rs.) | 2.95 | 1.97 | 0.87 | 0.28 | 1.92 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 16.97 | 13.67 | 9.51 | 6.74 | 16.24 | |
| PBIT Margin (%) | 14.62 | 11.39 | 6.57 | 2.82 | 13.09 | |
| PBT Margin (%) | 13.85 | 10.42 | 5.45 | 1.94 | 11.96 | |
| Net Profit Margin (%) | 10.64 | 8.04 | 3.92 | 1.47 | 9.26 | |
| NP After MI And SOA Margin (%) | 10.64 | 8.04 | 3.92 | 1.47 | 8.78 | |
| Return on Networth/Equity (%) | 18.98 | 14.82 | 7.60 | 2.61 | 17.76 | |
| Return on Capital Employed (%) | 24.62 | 19.95 | 12.06 | 4.75 | 16.96 | |
| Return on Assets (%) | 13.37 | 10.00 | 4.88 | 1.50 | 10.87 | |
| Total Debt/Equity (X) | 0.03 | 0.18 | 0.25 | 0.25 | 0.20 | |
| Asset Turnover Ratio (%) | 125.65 | 124.43 | 124.65 | 102.04 | 123.70 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.59 | 2.28 | 1.92 | 1.63 | 1.70 | |
| Quick Ratio (X) | 1.54 | 1.02 | 0.99 | 0.99 | 1.05 | |
| Inventory Turnover Ratio (X) | 4.69 | 3.41 | 4.18 | 4.04 | 5.32 | |
| Dividend Payout Ratio (NP) (%) | 24.43 | 5.52 | 6.88 | 150.44 | 21.37 | |
| Dividend Payout Ratio (CP) (%) | 20.01 | 4.30 | 3.93 | 41.16 | 15.73 | |
| Earnings Retention Ratio (%) | 75.57 | 94.48 | 93.12 | -50.44 | 78.63 | |
| Cash Earnings Retention Ratio (%) | 79.99 | 95.70 | 96.07 | 58.84 | 84.27 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 18.97 | 11.80 | 5.87 | 3.20 | 11.52 | |
| Interest Coverage Ratios (Post Tax) (%) | 18.97 | 11.80 | 5.87 | 3.20 | 11.52 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 507.17 | 1,103.73 | 1,392.56 | 2,031.71 | 1,964.48 | |
| EV/Net Operating Revenue (X) | 0.45 | 1.10 | 1.53 | 2.65 | 2.20 | |
| EV/EBITDA (X) | 2.63 | 8.07 | 16.03 | 39.25 | 13.54 | |
| MarketCap/Net Operating Revenue (X) | 0.50 | 1.02 | 1.42 | 2.52 | 2.12 | |
| Retention Ratios (%) | 75.56 | 94.47 | 93.11 | -50.44 | 78.62 | |
| Price/BV (X) | 0.89 | 1.87 | 2.75 | 4.45 | 4.28 | |
| Price/Net Operating Revenue | 0.50 | 1.02 | 1.42 | 2.52 | 2.12 | |
| Earnings Yield | 0.21 | 0.08 | 0.03 | 0.01 | 0.04 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y